30 completed, 5 unknown, 3 terminated, 1 withdrawn. 39 Phase 2, 4 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 39 | Completed 30, Unknown 5, Terminated 3, Withdrawn 1 |
| Phase 1 | 4 | Completed 2, Unknown 2 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Precancerous Condition: new trials by email Literature Review of Precancerous Condition trials Research Report on Precancerous Condition
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combined Digital Colposcopy Analysis to Improve Cervical Precancer and Cancer Detection Multispectral Digital Colposcope (MDC) - Cervical Cancer, Precancerous Condition | Phase 2 | Completed | British Columbia Cancer Agency | 551 | 2012-12-01 | 2019-07-05 |
| Vandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck Lesions vandetanib, placebo, immunohistochemistry staining method - Lip and Oral Cavity Squamous Cell Carcinoma, Oral Cavity Verrucous Carcinoma | Phase 2 | Completed | University of Chicago | 20 | 2012-01-01 | 2021-01-14 |
| Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine, laboratory biomarker analysis - Anal Cancer, Nonneoplastic Condition | Phase 2 | Completed | AIDS Malignancy Consortium | 149 | 2011-06-28 | 2020-08-11 |
| Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer cetuximab, intensity-modulated radiation therapy (IMRT), Paclitaxel - Head and Neck Cancer, Precancerous Condition | Phase 2 | Completed | Eastern Cooperative Oncology Group | 90 | 2010-08-11 | 2023-06-28 |
| Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma defined green tea catechin extract, gene expression analysis, protein analysis - Multiple Myeloma and Plasma Cell Neoplasm, Precancerous Condition | Phase 2 | Terminated | Barbara Ann Karmanos Cancer Institute | 8 | 2009-11-01 | 2015-03-27 |
| Broccoli Sprout Extract in Treating Women Who Have Had a Mammogram and Breast Biopsy broccoli sprout extract, placebo - Breast Cancer, Precancerous Condition | Phase 2 | Completed | OHSU Knight Cancer Institute | 54 | 2009-08-01 | 2017-04-27 |
| Tethered Capsule Endoscope in Screening Participants for Barrett Esophagus questionnaire administration, comparison of screening methods, diagnostic endoscopic procedure - Esophageal Cancer, Precancerous Condition | Phase 1 / Phase 2 | Unknown | US Department of Veterans Affairs | 50 | 2009-05-01 | 2014-01-10 |
| Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of Melanoma sulindac, placebo, laboratory biomarker analysis - Precancerous Condition | Phase 2 | Completed | National Cancer Institute (NCI) | 50 | 2009-02-01 | 2017-12-26 |
| Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders anti-thymocyte globulin, busulfan, cyclophosphamide - Graft Versus Host Disease, Leukemia | Phase 2 | Unknown | Institut Paoli-Calmettes | 50 | 2008-01-01 | 2010-01-28 |
| Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection Gardasil - Infection, Precancerous Condition | Phase 2 | Completed | AIDS Malignancy Consortium | 112 | 2007-11-01 | 2023-11-14 |
| Cidofovir in Treating HIV-Infected Patients With High-Grade Squamous Intraepithelial Lesions of the Skin Near the Anus cidofovir, DNA methylation analysis, gene expression analysis - Anal Cancer, Precancerous Condition | Phase 2 | Completed | AIDS Malignancy Consortium | 33 | 2007-09-01 | 2015-12-21 |
| Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy darbepoetin alfa, epoetin alfa, fatigue assessment and management - Anemia, Leukemia | Phase 2 | Completed | Mayo Clinic | 239 | 2007-05-01 | 2017-02-10 |
| Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer anti-thymocyte globulin, cyclophosphamide, etoposide - Chronic Myeloproliferative Disorders, Graft Versus Host Disease | Phase 2 | Completed | City of Hope Medical Center | 32 | 2007-05-01 | 2014-09-10 |
| Lovastatin in Treating Patients At High Risk of Melanoma lovastatin, placebo, biopsy - Precancerous Condition, Stage 0 Melanoma | Phase 2 | Completed | National Cancer Institute (NCI) | 80 | 2007-05-01 | 2014-10-31 |
| Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract cetuximab - Head and Neck Cancer, Precancerous Condition | Phase 2 | Completed | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 35 | 2007-05-01 | 2020-03-12 |
| Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer acetylsalicylic acid, placebo, laboratory biomarker analysis - Colon Cancer, Precancerous Condition | Phase 2 | Completed | National Cancer Institute (NCI) | 79 | 2007-03-01 | 2017-05-31 |
| Folic Acid Clinical Trial for the Prevention of Cervical Cancer folic acid, placebo - Cervical Cancer, Precancerous Condition | Phase 2 | Completed | University of Alabama at Birmingham | 368 | 2007-03-01 | 2015-10-08 |
| Green Tea Extract in Treating Current or Former Smokers With Bronchial Dysplasia defined green tea catechin extract, placebo - Lung Cancer, Precancerous Condition | Phase 2 | Terminated | British Columbia Cancer Agency | 23 | 2006-10-01 | 2012-03-09 |
| Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia sulindac, placebo - Precancerous Condition, Stage I Non-small Cell Lung Cancer | Phase 2 | Completed | National Cancer Institute (NCI) | 61 | 2006-08-01 | 2014-05-23 |
| 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis tanespimycin - Chronic Myeloproliferative Disorders, Leukemia | Phase 2 | Completed | National Institutes of Health Clinical Center (CC) | 37 | 2006-05-01 | 2012-03-15 |
Showing 20 of 39. Sign in to see all of them.
Precancerous Conditions (39) · Monoclonal Gammopathy of Undetermined Significance (7) · Multiple Myeloma (7) · Neoplasms, Plasma Cell (7) · Uterine Cervical Dysplasia (7) · Burkitt Lymphoma (6) · Leukemia (6) · Leukemia, Lymphocytic, Chronic, B-Cell (6) · Lymphoma (6) · Lymphoma, B-Cell, Marginal Zone (6) · Lymphoma, Follicular (6) · Lymphoma, Large B-Cell, Diffuse (6) · Lymphoma, Large-Cell, Immunoblastic (6) · Lymphoma, Mantle-Cell (6) · Lymphoma, Non-Hodgkin (6)
Neoplasms (39) · Neoplasms by Site (24) · Neoplasms by Histologic Type (14) · Pathological Conditions, Signs and Symptoms (13) · DNA Virus Infections (10) · Disease Attributes (10) · Genital Diseases (10) · Immune System Diseases (10) · Pathologic Processes (10) · Tumor Virus Infections (10) · Urogenital Diseases (10) · Virus Diseases (10) · Blood Protein Disorders (9) · Hematologic Diseases (9) · Hemic and Lymphatic Diseases (9)
Biopsy (3) · Methotrexate (3) · Sulindac (3) · fludarabine phosphate (3) · Antilymphocyte Serum (2) · Busulfan (2) · Celecoxib (2) · Cetuximab (2) · Cyclophosphamide (2) · Cyclosporine (2) · Epoetin Alfa (2) · Gene Expression Profiling (2) · Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (2) · Mycophenolic Acid (2) · Peripheral Blood Stem Cell Transplantation (2)
National Cancer Institute (NCI) (5) · AIDS Malignancy Consortium (3) · British Columbia Cancer Agency (3) · Mayo Clinic (2) · OHSU Knight Cancer Institute (2) · Roswell Park Cancer Institute (2) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (2) · University of Alabama at Birmingham (2) · Albert Einstein College of Medicine (1) · Alliance for Clinical Trials in Oncology (1) · Barbara Ann Karmanos Cancer Institute (1) · Children's Hospital of Philadelphia (1) · City of Hope Medical Center (1) · Dana-Farber/Brigham and Women's Cancer Center (1) · Eastern Cooperative Oncology Group (1)
United States (36) · Canada (4) · France (1) · Puerto Rico (1)
Joel Palefsky, MD (3) · Michele Follen, MD, PhD (2) · Stephen Lam, MD (2) · Antonio T. Fojo, MD, PhD (1) · Benn E. Smith, MD (1) · Bobbie S. Gostout, MD (1) · Carolyn D. Runowicz, MD (1) · Chandrika J. Piyathilake, PhD, MPH (1) · Charles L. Loprinzi, M.D. (1) · Cornelia L. Trimble, MD (1) · Craig A. Elmets, MD (1) · Didier Blaise, MD (1) · Elizabeth Stier, MD (1) · Hector R. Nava, MD, FACS (1) · Hemant Roy (1)
PMID 17586030, PMID 19118066, PMID 19170225, PMID 20812850, PMID 21115882, PMID 21636546, PMID 21907959, PMID 23032420, PMID 23261228, PMID 25057165, PMID 26329135, PMID 26503631, PMID 26511489, PMID 28029303, PMID 30658128, PMID 31299087, PMID 34907980, PMID 4326367
P30CA015083 (3), U01CA121947 (3), N01CN35000 (2), P30CA006973 (2), P30CA023074 (2), N01CN35157 (1), N01CN35158 (1), N01CN35160 (1), P01CA027502 (1), P01CA082710 (1), P01CA096964 (1), P30CA016058 (1), P30CA016672 (1), P30CA022453 (1), P30CA033572 (1)